Early parenteral use of proton pump inhibitors in the complex treatment of acute poisoning with cauterant agents

References

1. Luzhnikov E.A., ed. Meditsinskaya toksikologiya [Medical toxicology]. Moscow: GEOTAR-MediaPubl., 2012. 928 p. (In Russian).

2. Volkov S.V., Ermolov A.S., Luzhnikov E.A. Khimicheskie ozhogi pishchevoda i zheludka (Endoskopicheskaya diagnostika i lazeroterapiya) [Chemical burns of the esophagus and stomach (Endoscopic diagnostics and laser therapy)]. Moscow: MEDPRAKTIKA-M Publ., 2005. 120 p. (In Russian).

3. Pesnya–Prasolova E.A., Il’yashenko K.K., Pinchuk T.P. et al. Narusheniya kislotoobrazuyushchey funktsii zheludka u bol’nykh s otravleniyami prizhigayushchimi zhidkostyami [Impaired gastric acid secretion in patients poisoned by cauterizing liquids]. Anesteziologiya ireanimatologiya. 2005; 6: 64–67. (In Russian).

4. Andreev D.N., Dicheva D.T., Lebedeva E.G., Partsvania-Vinogradova E.V. Farmakologicheskie osnovy primeneniya ingibitorov protonnoy pompy [Pharmacological basis for the use of proton pump inhibitors].Farmateka. 2014; 14: 62–69. (In Russian).

5. Wolfe M.M., Sachs G. Acid suppression: Optimizing therapy for gastroduodenal healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology. 2000; 118 (2Suppl1): 9–31.

6. Welage L.S. Overview of pharmacologic agents for acid suppression in critically ill patients. Am J Health Syst Pharm. 2005; 62 (10 Suppl 2): 4–10.

7. Khuroo M.S., Yattoo G.N., Javid G., et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med. 1997; 336 (15):1054–1058.

8. Shcherbakov P. L., Mikheeva O.M., Vasnev O.S. Ispol’zovanie in”ektsionnykh form kislotopodavlyayushchikh preparatov v gastroenterologii [The use of injectable acid-suppresseddrugs in gastroenterology]. Lechashchiy vrach. 2008; 6: 27–30. (In Russian).

9. Pasechnikov V.D. Klyuchi k vyboru optimal’nogo ingibitora protonnoy pompy dlya terapii kislotozavisimykh zabolevaniy [Keys to select the optimal proton pump inhibitor for treatment of acid-related diseases]. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii. 2004; 3: 32–40. (In Russian).

10. Horn J. Review article relationship between the metabolism and efficacy of proton pump inhibitors — focus on rabeprazole. Aliment Pharmacol Ther. 2004; 20 Suppl 6: 11–19.

11. Luzhnikov E.A. Klinicheskaya toksikologiya: uchebnik [Clinical toxicology]. 3^rd ed., ed. and exp. Moscow: Meditsina Publ., 1999. 416 p. (In Russian).

12. Green F.W., Kaplan M.M., Curtis L.E., Levine P.H. Effect of acid and pepsin on blood coagulation and platelet aggregation: A possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978; 74 (1): 38–43.

13. Fennerty M.B. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: Rationale for therapeutic benefits of acid suppression. Crit Care Med. 2002; 30 (6 Suppl): 351–355.